Psychology & Intimacy New ETH Zurich Alzheimer’s Treatment Target and Compound 10 Show Promise in Preclinical Studies September 21, 2026 Rebecca Shoemaker The global scientific community continues to grapple with one of modern medicine’s most elusive challenges: halting the relentless progression of Alzheimer’s disease. Amid decades of incremental progress and numerous clinical…
Psychology & Intimacy Beyond Amyloid and Tau: Multidisciplinary Research Unlocks the Three-Dimensional Genome Architecture of Alzheimer’s Disease September 21, 2026 Rebecca Shoemaker Researchers across multiple premier academic institutions have unveiled a groundbreaking perspective on Alzheimer’s disease, identifying a previously underexplored feature of its molecular pathology that could fundamentally reshape future therapeutic development.…
Psychology & Intimacy New Research Reveals How APOE4 Triggers Early Brain Changes and Identifies Potential Pathway for Alzheimer’s Reversal September 20, 2026 Rebecca Shoemaker Millions of individuals worldwide carry APOE4, widely recognized as the most potent genetic risk factor for the development of late-onset Alzheimer’s disease. For decades, the precise biological mechanisms by which…
Human Sexuality Research & Journals New Alzheimer’s disease diagnostics and psychological clinical perspectives September 17, 2026 Lina Irawan The landscape of Alzheimer’s disease (AD) management is undergoing a profound paradigm shift. Driven by breakthroughs in blood-based biomarkers (BBMs) such as plasma phosphorylated tau 217 (p-tau217), clinicians can now…
Psychology & Intimacy New Lund University Research Links Modifiable Lifestyle and Health Factors to Specific Brain Changes in Alzheimer’s and Vascular Dementia September 16, 2026 Rebecca Shoemaker Nearly half of all global dementia cases could theoretically be prevented or delayed by addressing modifiable lifestyle and health factors, according to landmark epidemiological estimates. While medical science has long…
Sexual Health & Medical Wellness Common respiratory bacterium linked to Alzheimer’s disease progression in groundbreaking Cedars-Sinai study September 15, 2026 Susilo Ahmad A persistent respiratory bacterium, traditionally associated with pneumonia and sinus infections, may be a significant, previously overlooked catalyst in the development and progression of Alzheimer’s disease. New research published in…
Psychology & Intimacy ETH Zurich Researchers Develop Experimental Compound That Targets GRK2 Enzyme to Slow Alzheimer’s Progression and Protect Mitochondria September 14, 2026 Rebecca Shoemaker A team of molecular pharmacologists at ETH Zurich has developed an experimental chemical substance, designated as Compound 10, that offers a novel therapeutic approach to slowing the neurodegenerative progression of…
Psychology & Intimacy Beyond Plaques and Tangles: Scientists Uncover 3D Genome Disruption as a New Frontier in Alzheimer’s Disease Research September 13, 2026 Rebecca Shoemaker In a significant pivot from decades of neuroscientific orthodoxy, an interdisciplinary team of researchers has uncovered a fundamental yet previously overlooked structural dimension of Alzheimer’s disease. Published in the prestigious…
Psychology & Intimacy Groundbreaking Gladstone Institutes Study Reveals How APOE4 Accelerates Alzheimer’s Risk and Identifies Potential Reversal Target September 12, 2026 Rebecca Shoemaker The pursuit of effective interventions for Alzheimer’s disease has long been stymied by the complex interplay between genetic predisposition and neurodegeneration. Millions of individuals globally carry the APOE4 gene variant,…
Psychology & Intimacy The APOE2 Gene Variant Offers Enhanced Neuronal Protection Against DNA Damage and Cellular Senescence, Unlocking New Avenues for Alzheimer’s Research July 24, 2026 Rebecca Shoemaker For decades, scientists have observed a remarkable correlation: individuals carrying the APOE2 form of the apolipoprotein E gene tend to enjoy longer lifespans and exhibit a significantly lower incidence of…
